MedTrace Logo

Reasons and Risk Factors for Unplanned Spinal Re-operation

NCT05995327 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70000

Last updated 2023-08-24

No results posted yet for this study

Summary

Unplanned re-operation is one of the common negative indicators reflecting the quality and safety of surgery in the medical industry and has become one of the ten goals for the improvement of national medical quality and safety in China since 2022, while about 40% of unplanned re-operations in Peking University Third Hospital in recent years occur in spine patients of the orthopedics department. This project intends to establish a high-quality and sustainable ambispective disease cohort for spine surgery in Peking University Third Hospital based on the unplanned re-operations that occurred in the Orthopedics Department of Peking University Third Hospital from January 2012 to December 2025. The investigators further summarize and analyze clinical causes and risk factors of re-operations, aiming to explore scientific coping strategies and provide reference for continuous improvement of medical service quality.

Conditions

  • Degeneration Spine
  • Spine Deformity
  • Spine Tumor
  • Spine Fracture

Sponsors & Collaborators

  • PUTH Beifang Hospital

    collaborator UNKNOWN

  • PUTH Chongli Hospital

    collaborator UNKNOWN

  • PUTH Qinhuangdao Hospital

    collaborator UNKNOWN

  • PUTH Yanqing Hospital

    collaborator UNKNOWN

  • Peking University Third Hospital

    lead OTHER

Principal Investigators

  • Weishi Li · Peking University Third Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-01
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05995327 on ClinicalTrials.gov